Adagene Inc.
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
ADAG | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 4F, BUILDING C14, NO. 218, XINGHU STREET, 0 JIANGSU
- Website:
- https://www.adagene.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Adagene Inc. is a platform-driven, clinical-stage biotechnology company specializing in the discovery and development of novel antibody-based immunotherapies for cancer treatment. The company's core technology is a dynamic discovery engine that leverages a deep understanding of protein folding and molecular motion. By integrating computational biology, artificial intelligence, and precision engineering, Adagene designs and selects unique antibody candidates. This approach aims to build a pipeline of therapeutic assets with novel mechanisms of action to address unmet needs in oncology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Adagene Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Adagene Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Adagene Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
